Literature DB >> 23545893

Adult mortality in a randomized trial of mass azithromycin for trachoma.

Jeremy D Keenan, Paul M Emerson, Bruce D Gaynor, Travis C Porco, Thomas M Lietman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23545893      PMCID： PMC3748947          DOI： 10.1001/jamainternmed.2013.3041

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  9 in total

1.  Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children.

Authors:  Christian L Coles; Joshua Levens; Jessica C Seidman; Harran Mkocha; Beatriz Munoz; Sheila West
Journal:  Pediatr Infect Dis J       Date:  2012-04       Impact factor: 2.129

2.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  On estimating efficacy from clinical trials.

Authors:  A Sommer; S L Zeger
Journal:  Stat Med       Date:  1991-01       Impact factor: 2.373

4.  Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children.

Authors:  Christian L Coles; Jessica C Seidman; Joshua Levens; Harran Mkocha; Beatriz Munoz; Sheila West
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

5.  Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.

Authors:  Jenafir I House; Berhan Ayele; Travis C Porco; Zhaoxia Zhou; Kevin C Hong; Teshome Gebre; Kathryn J Ray; Jeremy D Keenan; Nicole E Stoller; John P Whitcher; Bruce D Gaynor; Paul M Emerson; Thomas M Lietman
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

6.  Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.

Authors:  Jaya D Chidambaram; Wondu Alemayehu; Muluken Melese; Takele Lakew; Elizabeth Yi; Jenafir House; Vicky Cevallos; Zhaoxia Zhou; Kathryn Maxey; David C Lee; Brett L Shapiro; Muthiah Srinivasan; Travis Porco; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

7.  Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.

Authors:  Travis C Porco; Teshome Gebre; Berhan Ayele; Jenafir House; Jeremy Keenan; Zhaoxia Zhou; Kevin Cyrus Hong; Nicole Stoller; Kathryn J Ray; Paul Emerson; Bruce D Gaynor; Thomas M Lietman
Journal:  JAMA       Date:  2009-09-02       Impact factor: 56.272

8.  Ten years left to eliminate blinding trachoma.

Authors:  Danny Haddad
Journal:  Community Eye Health       Date:  2010-09

9.  Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.

Authors:  Alison H Skalet; Vicky Cevallos; Berhan Ayele; Teshome Gebre; Zhaoxia Zhou; James H Jorgensen; Mulat Zerihun; Dereje Habte; Yared Assefa; Paul M Emerson; Bruce D Gaynor; Travis C Porco; Thomas M Lietman; Jeremy D Keenan
Journal:  PLoS Med       Date:  2010-12-14       Impact factor: 11.069
  9 in total
  8 in total

1.  Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting.

Authors:  Daozhou Gao; Thomas M Lietman; Travis C Porco
Journal:  Math Biosci       Date:  2015-02-26       Impact factor: 2.144

2.  Azithromycin-containing intermittent preventive treatment in pregnancy affects gestational weight gain, an important predictor of birthweight in Papua New Guinea - an exploratory analysis.

Authors:  Holger W Unger; Regina A Wangnapi; Maria Ome-Kaius; Philippe Boeuf; Stephan Karl; Ivo Mueller; Stephen J Rogerson
Journal:  Matern Child Nutr       Date:  2015-09-15       Impact factor: 3.092

3.  Impact of intermittent preventive treatment in pregnancy with azithromycin-containing regimens on maternal nasopharyngeal carriage and antibiotic sensitivity of Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus: a cross-sectional survey at delivery.

Authors:  Holger W Unger; Celestine Aho; Maria Ome-Kaius; Regina A Wangnapi; Alexandra J Umbers; Wanda Jack; Alice Lafana; Audrey Michael; Sarah Hanieh; Peter Siba; Ivo Mueller; Andrew R Greenhill; Stephen J Rogerson
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

Review 4.  Trachoma.

Authors:  Anthony W Solomon; Matthew J Burton; Emily W Gower; Emma M Harding-Esch; Catherine E Oldenburg; Hugh R Taylor; Lamine Traoré
Journal:  Nat Rev Dis Primers       Date:  2022-05-26       Impact factor: 52.329

5.  "Rapid impact" 10 years after: The first "decade" (2006-2016) of integrated neglected tropical disease control.

Authors:  Peter J Hotez; Alan Fenwick; Sarah E Ray; Simon I Hay; David H Molyneux
Journal:  PLoS Negl Trop Dis       Date:  2018-05-24

6.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.

Authors:  Jeremy D Keenan; Ahmed M Arzika; Ramatou Maliki; Nameywa Boubacar; Sanoussi Elh Adamou; Maria Moussa Ali; Catherine Cook; Elodie Lebas; Ying Lin; Kathryn J Ray; Kieran S O'Brien; Thuy Doan; Catherine E Oldenburg; E Kelly Callahan; Paul M Emerson; Travis C Porco; Thomas M Lietman
Journal:  N Engl J Med       Date:  2019-06-06       Impact factor: 91.245

7.  Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.

Authors:  Jeremy D Keenan; Robin L Bailey; Sheila K West; Ahmed M Arzika; John Hart; Jerusha Weaver; Khumbo Kalua; Zakayo Mrango; Kathryn J Ray; Catherine Cook; Elodie Lebas; Kieran S O'Brien; Paul M Emerson; Travis C Porco; Thomas M Lietman
Journal:  N Engl J Med       Date:  2018-04-26       Impact factor: 91.245

Review 8.  The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin.

Authors:  Jack Cook; Milton L Pressler; Bharat Damle; Demissie Alemayehu; Charles A Knirsch
Journal:  Clin Transl Sci       Date:  2020-09-21       Impact factor: 4.438
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.